111 (YI) EBT Growth (1y) (2018 - 2025)
111 (YI) EBT Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 40.26% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 124.90% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -41.05% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 3.45% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 46.02% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | -200.96% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -22.44% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | -56.83% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -242.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.02% |
| Sep 30, 2025 | 58.99% |
| Jun 30, 2025 | -262.50% |
| Mar 31, 2025 | -174.79% |
| Dec 31, 2024 | 94.05% |
| Sep 30, 2024 | 95.67% |
| Jun 30, 2024 | 95.53% |
| Mar 31, 2024 | 87.05% |
| Dec 31, 2023 | -91.43% |
| Sep 30, 2023 | 5.74% |
| Jun 30, 2023 | 50.55% |
| Mar 31, 2023 | 82.31% |
| Dec 31, 2022 | 5.50% |
| Sep 30, 2022 | 52.88% |
| Jun 30, 2022 | 55.59% |
| Mar 31, 2022 | 38.42% |
| Dec 31, 2021 | 24.18% |
| Sep 30, 2021 | -57.11% |
| Jun 30, 2021 | -116.33% |
| Mar 31, 2021 | -45.98% |